Microbiology | European Cystic Fibrosis Society (ECFS)

Molecular fingerprinting of Pseudomonas aeruginosa from PWCF, and a UK reference laboratory investigation into frequency of cross-infection

Airway infection increases Pseudomonas aeruginosa acquisition

Eradication of Nontuberculous Mycobacteria in People with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/Ivacaftor

Postage of sputum samples from home to clinic can be used for microbiology surveillance

Lung infection in people with advanced cystic fibrosis lung disease

Risk of Human papilloma virus infection and of cervical lesions in females with cystic fibrosis

The Presence of Clostridioides difficile in Stool Samples of Children with Cystic Fibrosis

Are we missing Aspergillus in airway samples due to bacteria that may also be present?

ivacaftor does not change gut bacteria, inflammation or pancreas function

Mycobacterium abscessus smooth and rough colony variants in cystic fibrosis patients

1
2
3
4
next
last